BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36641437)

  • 1. Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments.
    Wang H; Wu Z; Fan X; Wu C; Lu S; Geng L; Stalin A; Zhu Y; Zhang F; Huang J; Liu P; Li H; You L; Wu J
    Chin Med; 2023 Jan; 18(1):7. PubMed ID: 36641437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology.
    Wang H; Wu Z; Liu Y; Wang M; Stalin A; Guo S; Li J; Wu C; Zhang J; Tan Y; Huang Z; Lu S; Fan X; Wu J
    J Ethnopharmacol; 2022 Mar; 285():114852. PubMed ID: 34838619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.
    Lu S; Huang J; Zhang J; Wu C; Huang Z; Tao X; You L; Stalin A; Chen M; Li J; Tan Y; Wu Z; Geng L; Li Z; Fan Q; Liu P; Lin Y; Zhao C; Wu J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117209. PubMed ID: 37757991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer.
    Zhang W; Peng W; Li Y; Pan T; Feng F; Xu J; Zhou X
    Evid Based Complement Alternat Med; 2022; 2022():8350218. PubMed ID: 36523419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
    Zhuang Z; Lin T; Luo L; Zhou W; Wen J; Huang H; Liu Z; Lin L
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33506873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
    Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
    J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats.
    Lu Y; Wang Y; He Y; Pan J; Jin Y; Zheng L; Huang Y; Li Y; Liu W
    J Ethnopharmacol; 2022 Mar; 286():114930. PubMed ID: 34952190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Effects and Molecular Mechanisms of Shenmai Injection in Treating Acute Pancreatitis: Network Pharmacology Analysis and Experimental Verification.
    He Y; Hu C; Liu S; Xu M; Liang G; Du D; Liu T; Cai F; Chen Z; Tan Q; Deng L; Xia Q
    Drug Des Devel Ther; 2022; 16():2479-2495. PubMed ID: 35941928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
    Taha KF; Khalil M; Abubakr MS; Shawky E
    J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aidi injection reduces doxorubicin-induced cardiotoxicity by inhibiting carbonyl reductase 1 expression.
    Lu Y; Liu W; Lv T; Wang Y; Liu T; Chen Y; Jin Y; Huang J; Zheng L; Huang Y; He Y; Li Y
    Pharm Biol; 2022 Dec; 60(1):1616-1624. PubMed ID: 35980105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese patent medicine Aidi injection for cancer care: An overview of systematic reviews and meta-analyses.
    Yang M; Shen C; Zhu SJ; Zhang Y; Jiang HL; Bao YD; Yang GY; Liu JP
    J Ethnopharmacol; 2022 Jan; 282():114656. PubMed ID: 34551361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of eleven active compounds of Aidi injection in rat plasma and its application to comparative pharmacokinetic study.
    Liu R; Ma R; Yu C; Bi CW; Yin Y; Xu H; Shang H; Bi K; Li Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():105-113. PubMed ID: 26277443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematically characterized mechanism of treatment for lumbar disc herniation based on Yaobitong capsule ingredient analysis in rat plasma and its network pharmacology strategy by UPLC-MS/MS.
    Deng Y; Gao X; Feng T; Wang Z; Xiao W; Xiong Z; Zhao L
    J Ethnopharmacol; 2020 Oct; 260():113097. PubMed ID: 32531413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating network pharmacology and pharmacological evaluation to explore the protective mechanism of Ershiwuwei Zhenzhu pill in ischemic stroke.
    Wang C; Luo Q; Que H; Luo X; Zhang B; Ding Y; Tan R; Gu J; Gong P
    J Ethnopharmacol; 2023 Jan; 301():115847. PubMed ID: 36272491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
    Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating network pharmacology, UPLC-Q-TOF-MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease.
    Shen ZJ; Fu YB; Hou JL; Lin LN; Wang XY; Li CY; Yang YX
    Chin Med; 2022 Dec; 17(1):143. PubMed ID: 36566207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of Qingwei Powder in treatment of periodontitis based on UPLC-Q-TOF-MS, GC-MS, network pharmacology and molecular docking].
    Meng Y; Jiang ZT; Yan GJ; Shen J; Sun KP; Wang YY; Cao JN; Xia MY; Pan JH
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2778-2787. PubMed ID: 35718498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology.
    Yuan J; Zhao D; Liu XF; Tian YG; Zhang HJ; Feng SX; Li JS
    Sci Rep; 2022 Jul; 12(1):12476. PubMed ID: 35864295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.